| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/20/2007 | CN1984922A Substituted prolines as inhibitors of hepatitis c virus NS3 serine protease |
| 06/20/2007 | CN1984670A Cyclosporins to treat alzheimer's disease |
| 06/20/2007 | CN1982331A Recombinant thymus pentapeptide structural analogs, its production and use |
| 06/20/2007 | CN1982330A Methods for preparing purified lipopeptides |
| 06/20/2007 | CN1322005C Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321687C Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/19/2007 | US7232881 Peptide containing Ser-Ser-Ser-Arg |
| 06/19/2007 | US7232803 Molecule comprising backbone of 2-35 non-hydrogen atoms in length, having covalently attached bulky lipoophilic groups and having more cationic than anionic moiety in manufacturing medicament for destabilising microbial cell membranes |
| 06/19/2007 | US7232802 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 06/19/2007 | US7232801 Administering a peptide whose sequence coincide with regions of the IL-16 receptor (CD4) to interfere with or prevent binding to an IL-16 receptor; treating asthma, arthritis, IBD, Systemic Lupus, multiple sclerosis, Graves opthalmopathy, atopic rhinitis, atopic dermatitis and bullous pemphigoid |
| 06/19/2007 | US7232559 Diagnostic agents for pancreatic exocrine function |
| 06/19/2007 | CA2189690C Novel active peptide and its preparation |
| 06/16/2007 | CA2557055A1 Peptides for stimulating an immune response against melanoma |
| 06/14/2007 | WO2007067979A2 Targeting vector-phospholipid conjugates |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |
| 06/14/2007 | WO2007066018A2 Novel peptides and the biological use thereof |
| 06/14/2007 | WO2007065973A1 Labeling reactants suitable for solid-phase synthesis |
| 06/14/2007 | WO2007065691A2 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 06/14/2007 | WO2007065451A1 Means for preventing and treating rhinitis of different ethiology, method for the production thereof, a pharmaceutical composition based thereon and a preventing and treating method |
| 06/14/2007 | WO2007038407A3 Compositions and methods for treating nervous system disorders |
| 06/14/2007 | WO2007014253A3 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 06/14/2007 | WO2006030291A3 Radiofluorinated peptides |
| 06/14/2007 | US20070135618 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 06/14/2007 | US20070135351 polymer conjugated drug; genetically engineered truncated analogs of significantly lower-molecular-weight and having equal or better potency, pharmacokinetic properties and pharmacological properties as existing Y2R agonists; also pegylated analogs; treating obesity; dietetics; metabolic disorders |
| 06/14/2007 | US20070135350 Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing a B-Cell Associated Protein |
| 06/14/2007 | US20070135339 Bacteriocin inducer peptides |
| 06/14/2007 | US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus |
| 06/14/2007 | US20070134261 Effectors of innate immunity |
| 06/14/2007 | US20070134221 Stabilizing peptides |
| 06/14/2007 | US20070134155 useful in the treatment of heart failure, cardiac arrhythmias and other diseases where fibrosis is prominent such as in COPD, liver fibrosis, and atherosclerosis comprising a targeting moiety that demonstrates a higher binding affinity to the AT1 receptor than the native octapeptide Ang II |
| 06/14/2007 | DE102005059242A1 Molekulare Marker für eine Tumordiagnose und -therapie Molecular markers for tumor diagnosis and therapy |
| 06/14/2007 | CA2632714A1 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 06/14/2007 | CA2632708A1 Novel peptides and the biological use thereof |
| 06/14/2007 | CA2631716A1 Targeting vector-phospholipid conjugates |
| 06/13/2007 | EP1795561A1 Resin composition and molding thereof |
| 06/13/2007 | EP1795539A1 Cell penetrating peptides for intracellular delivery of molecules |
| 06/13/2007 | EP1795538A1 Peptides for inducing apoptosis in tumor cells |
| 06/13/2007 | EP1794298A2 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells |
| 06/13/2007 | EP1794187A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 06/13/2007 | EP1794182A2 Compounds that modulate trh actions and inhibit the trh-degrading enzyme |
| 06/13/2007 | EP1794180A1 Peptide cyclisation |
| 06/13/2007 | EP1793841A1 Peptide inhibitors of c-jun dimerization and uses thereof |
| 06/13/2007 | EP1793812A2 Antibiotic compound |
| 06/13/2007 | EP1625150B9 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 06/13/2007 | EP1379546B1 Peptide for the diagnosis and therapy of alzheimer's disease |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP0975354B1 Ligand/lytic peptide compositions and methods of use |
| 06/13/2007 | EP0876401B1 Methods for producing op-1 morphogen analogs |
| 06/13/2007 | EP0815136B1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 06/13/2007 | EP0742902B2 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 06/13/2007 | CN1980951A 抗微生物多肽 Antimicrobial peptides |
| 06/13/2007 | CN1978462A Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking |
| 06/12/2007 | US7229978 Chloromethylating an alcohol or phenol, especially camptothecin, propofol, etoposide, vitamin E, or cyclosporin A, and reacting the product with phosphoric acid in the presence of a base in a suitable polar aprotic solvent |
| 06/12/2007 | US7229961 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 06/12/2007 | US7229960 Administering a non-phosphorylated tripeptides |
| 06/12/2007 | US7229788 Mutating one or more of the amino acid residues of the amino acid sequence, in the tropoelastin, so that susceptibility of the tropoelastin to cleavage by thrombin, kallikrein or serum is reduced |
| 06/12/2007 | US7229777 Providing a library of peptides comprising a trpzip scaffold, contacting the library with the bioactive target molecule; selecting at least one peptide capable of forming a noncovalent complex with the bioactive target molecule from the library; isolating peptide |
| 06/12/2007 | US7229622 Synthetic chimeric fimbrin peptides |
| 06/12/2007 | CA2248772C Novel peptides which inhibit complement activation |
| 06/12/2007 | CA2122340C Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| 06/12/2007 | CA2057828C Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines |
| 06/12/2007 | CA2046649C Matrix metalloproteinase inhibitor peptides |
| 06/12/2007 | CA1341530C Inhibitors of angiogenin |
| 06/07/2007 | WO2007064997A2 Compounds and methods for inhibiting apoptosis |
| 06/07/2007 | WO2007063903A1 Novel peptide compound |
| 06/07/2007 | WO2007043715A9 Rna-binding peptide |
| 06/07/2007 | WO2007035531A3 Method for enhancing the effect of particulate benefit agents |
| 06/07/2007 | WO2007021900A3 Compositions and methods for treating wounds |
| 06/07/2007 | WO2007021572A3 Use of peptides that bind to tpo receptor |
| 06/07/2007 | WO2007000770A3 Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes |
| 06/07/2007 | WO2005058937A3 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/07/2007 | US20070129394 Rapamycin conjugated to peptides of up to 10 amino acid units through a carbamate linkage at position 42; coated stents; restenosis, cancer, autoimmune, transplant rejection |
| 06/07/2007 | US20070129309 Conjugates useful in the treatment of prostate cancer |
| 06/07/2007 | US20070129294 Compound and method of treatment |
| 06/07/2007 | US20070129289 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/07/2007 | US20070128657 Molecular libraries |
| 06/07/2007 | US20070128191 Polyclonal antibodies, preparation method thereof and use of same |
| 06/07/2007 | US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 06/07/2007 | CA2631731A1 Compounds and methods for inhibiting apoptosis |
| 06/07/2007 | CA2631292A1 Derivatised wt1 cancer antigen peptides and their use |
| 06/06/2007 | EP1792915A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2007 | EP1792911A1 Amino acid sequence essential to neurospecific gene expression |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1791969A2 A method of treating cancer |
| 06/06/2007 | EP1791857A1 Conformational switches in toxin folding and uses thereof |
| 06/06/2007 | EP1791571A2 Radiofluorinated peptides |
| 06/06/2007 | EP0941478B2 Assay method for peptide specific t-cells |
| 06/06/2007 | EP0920446B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/06/2007 | CN1977043A Natural IgM antibodies and inhibitors thereof |
| 06/06/2007 | CN1976947A Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 06/06/2007 | CN1976946A Supertype epitopes, oligonucleotides coding the same which induce effective CTL response against HCV and the use thereof |
| 06/06/2007 | CN1319987C Gamma-secretase inhibitors |
| 06/06/2007 | CN1319986C Process for separating and purifying polypeptide prepared by chemical synthesis |
| 06/05/2007 | US7228238 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 06/05/2007 | US7226911 Hair keratin-associated proteins |
| 06/05/2007 | US7226906 Analogs which are topically active but systemically less active, providing therapy to subjects without the risk of systemic side effects |
| 06/05/2007 | US7226905 Process for the preparation of cyclosporin derivatives |
| 06/05/2007 | US7226904 Agents and methods for promoting bone growth |